Inhibitec Antibodies, S.L. Cantabrian bi…

10-06-2019

Inhibitec Anticuerpos, S.L. Cantabrian (Spain) biotechnology company, spin-off of the CSIC and University of Cantabria, has developed a monoclonal antibody for a new therapeutic target. Last week,  it was in...